Date Filed | Type | Description |
08/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/03/2023 |
8-K
| Quarterly results |
05/16/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 4.8% stake in Verona Pharma plc |
05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/09/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/09/2023 |
8-K
| Quarterly results |
05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/01/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
04/25/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
04/20/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
03/21/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
03/21/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/07/2023 |
F-6EF
| Form F-6EF - Registration of American Depository Receipt shares, immediately effective: |
03/07/2023 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
03/07/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/07/2023 |
8-K
| Results of Operations and Financial Condition Interactive Data |
02/14/2023 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 10% stake in Verona Pharma plc |
02/09/2023 |
SC 13G/A
| Access Industries Holdings LLC reports a 5.4% stake in Verona Pharma plc |
02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
12/27/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/20/2022 |
8-K
| Quarterly results |
11/15/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
11/09/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
11/09/2022 |
8-K
| Quarterly results |
10/17/2022 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob... |
09/07/2022 |
SC 13D/A
| Growth Equity Opportunities Fund IV, LLC reports a 7.9% stake in Verona Pharma plc |
08/12/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
08/11/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
08/11/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
08/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
08/10/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
08/09/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
|